Insmed Incorporated
INSM
$68.12
$0.901.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.77% | 19.17% | 22.13% | 21.94% | 22.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.77% | 19.17% | 22.13% | 21.94% | 22.54% |
| Cost of Revenue | 29.43% | 30.76% | 29.63% | 29.15% | 21.91% |
| Gross Profit | 18.34% | 16.00% | 20.08% | 20.01% | 22.72% |
| SG&A Expenses | 44.14% | 33.85% | 24.26% | 21.19% | 23.79% |
| Depreciation & Amortization | 0.00% | 0.00% | -0.02% | -0.02% | -0.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.48% | 16.64% | 9.92% | 5.14% | 25.81% |
| Operating Income | -26.20% | -15.51% | -4.81% | 1.76% | -27.39% |
| Income Before Tax | -35.61% | -21.83% | -19.24% | -15.18% | -36.51% |
| Income Tax Expenses | 51.45% | 45.09% | 104.46% | 96.62% | 79.68% |
| Earnings from Continuing Operations | -35.66% | -21.91% | -19.44% | -15.36% | -36.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.66% | -21.91% | -19.44% | -15.36% | -36.62% |
| EBIT | -26.20% | -15.51% | -4.81% | 1.76% | -27.39% |
| EBITDA | -26.48% | -15.64% | -4.83% | 1.97% | -27.50% |
| EPS Basic | -13.60% | -4.45% | -5.41% | -2.95% | -22.78% |
| Normalized Basic EPS | -2.45% | 3.09% | 8.30% | 10.77% | -14.32% |
| EPS Diluted | -13.59% | -4.49% | -5.45% | -2.89% | -22.69% |
| Normalized Diluted EPS | -2.45% | 3.09% | 8.30% | 10.77% | -14.32% |
| Average Basic Shares Outstanding | 19.97% | 16.79% | 13.14% | 12.04% | 12.62% |
| Average Diluted Shares Outstanding | 19.97% | 16.79% | 13.14% | 12.04% | 12.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |